Page 3 - Stephan Becker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

WHO experts review AstraZeneca safety data as Europe witnesses wave of vaccine suspensions A World Health Organization (WHO) committee of experts was reviewing isolated cases of bleeding, blood clots and low platelet counts in people vaccinated in close dialogue with the European Medicines Agency (EMA), which was also meeting Reuters | March 16, 2021 | Updated 18:05 IST The European Union's largest members - Germany, France and Italy - suspended the use of AstraZeneca's vaccine on Monday Global health experts were under increasing pressure to clear up questions over the safety of AstraZeneca...

Boehringer Ingelheim: New SARS-CoV-2 Neutralizing Antibody enters Clinical Phase Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim collaborate on potential COVID-19 therapy and prevention BI 767551 (DZIF-10c) is a potent anti-SARS-CoV-2 antibody that has shown promising virus neutralizing properties in pre-clinical research Phase 1/2a clinical trials will evaluate the safety, pharmacokinetics, and antiviral activity of BI 767551 administered by intravenous infusion and by inhalation. The first patients have...

Credit: NIAID Cologne, Marburg, Braunschweig and Ingelheim, Germany, 18 December 2020 - Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer Ingelheim today announced the initiation of Phase 1/2a clinical investigation of BI 767551, a new SARS-CoV-2 neutralizing antibody. By combining UKK, UMR and DZIF's expertise in virology, immunology and clinical investigation with Boehringer Ingelheim's expertise in developing and manufacturing therapeutic antibodies, the partners developed BI 767551 as a potential new therapeutic ...